Bank of New York Mellon’s Prelude Therapeutics PRLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-28,613
| Closed | -$22K | – | 4214 |
|
|
2025
Q1 | $22K | Hold |
28,613
| – | – | ﹤0.01% | 4066 |
|
|
2024
Q4 | $36.5K | Hold |
28,613
| – | – | ﹤0.01% | 4069 |
|
|
2024
Q3 | $59.2K | Sell |
28,613
-7,663
| -21% | -$15.9K | ﹤0.01% | 4026 |
|
|
2024
Q2 | $138K | Sell |
36,276
-3,792
| -9% | -$14.4K | ﹤0.01% | 3993 |
|
|
2024
Q1 | $190K | Sell |
40,068
-10,532
| -21% | -$49.9K | ﹤0.01% | 3939 |
|
|
2023
Q4 | $216K | Buy |
50,600
+17,718
| +54% | +$75.7K | ﹤0.01% | 3922 |
|
|
2023
Q3 | $102K | Buy |
32,882
+2,066
| +7% | +$6.38K | ﹤0.01% | 4069 |
|
|
2023
Q2 | $139K | Buy |
+30,816
| New | +$139K | ﹤0.01% | 4039 |
|
|
2023
Q1 | – | Sell |
-28,879
| Closed | -$174K | – | 4426 |
|
|
2022
Q4 | $174K | Sell |
28,879
-300
| -1% | -$1.81K | ﹤0.01% | 4010 |
|
|
2022
Q3 | $193K | Sell |
29,179
-10
| -0% | -$66 | ﹤0.01% | 4031 |
|
|
2022
Q2 | $153K | Sell |
29,189
-30,631
| -51% | -$161K | ﹤0.01% | 4141 |
|
|
2022
Q1 | $412K | Buy |
59,820
+2,144
| +4% | +$14.8K | ﹤0.01% | 3826 |
|
|
2021
Q4 | $718K | Buy |
57,676
+23,364
| +68% | +$291K | ﹤0.01% | 3575 |
|
|
2021
Q3 | $1.07M | Buy |
34,312
+4,058
| +13% | +$127K | ﹤0.01% | 3349 |
|
|
2021
Q2 | $866K | Sell |
30,254
-782
| -3% | -$22.4K | ﹤0.01% | 3502 |
|
|
2021
Q1 | $1.35M | Buy |
31,036
+63
| +0.2% | +$2.73K | ﹤0.01% | 3163 |
|
|
2020
Q4 | $2.22M | Buy |
+30,973
| New | +$2.22M | ﹤0.01% | 2784 |
|